Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2019 3
2020 1
2021 3
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Vaccine Strategy in Melanoma.
Kwak M, Leick KM, Melssen MM, Slingluff CL Jr. Kwak M, et al. Among authors: melssen mm. Surg Oncol Clin N Am. 2019 Jul;28(3):337-351. doi: 10.1016/j.soc.2019.02.003. Epub 2019 Apr 15. Surg Oncol Clin N Am. 2019. PMID: 31079792 Free PMC article. Review.
Barriers to immune cell infiltration in tumors.
Melssen MM, Sheybani ND, Leick KM, Slingluff CL Jr. Melssen MM, et al. J Immunother Cancer. 2023 Apr;11(4):e006401. doi: 10.1136/jitc-2022-006401. J Immunother Cancer. 2023. PMID: 37072352 Free PMC article. Review.
Differential Expression of CD49a and CD49b Determines Localization and Function of Tumor-Infiltrating CD8+ T Cells.
Melssen MM, Lindsay RS, Stasiak K, Rodriguez AB, Briegel AM, Cyranowski S, Rutkowski MR, Conaway MR, Melief CJM, van der Burg SH, Eyo U, Slingluff CL Jr, Engelhard VH. Melssen MM, et al. Cancer Immunol Res. 2021 May;9(5):583-597. doi: 10.1158/2326-6066.CIR-20-0427. Epub 2021 Feb 22. Cancer Immunol Res. 2021. PMID: 33619119 Free PMC article.
Characterization and comparison of innate and adaptive immune responses at vaccine sites in melanoma vaccine clinical trials.
Melssen MM, Pollack KE, Meneveau MO, Smolkin ME, Pinczewski J, Koeppel AF, Turner SD, Sol-Church K, Hickman A, Deacon DH, Petroni GR, Slingluff CL Jr. Melssen MM, et al. Cancer Immunol Immunother. 2021 Aug;70(8):2151-2164. doi: 10.1007/s00262-020-02844-w. Epub 2021 Jan 16. Cancer Immunol Immunother. 2021. PMID: 33454795 Clinical Trial.
A multipeptide vaccine plus toll-like receptor agonists LPS or polyICLC in combination with incomplete Freund's adjuvant in melanoma patients.
Melssen MM, Petroni GR, Chianese-Bullock KA, Wages NA, Grosh WW, Varhegyi N, Smolkin ME, Smith KT, Galeassi NV, Deacon DH, Gaughan EM, Slingluff CL Jr. Melssen MM, et al. J Immunother Cancer. 2019 Jun 27;7(1):163. doi: 10.1186/s40425-019-0625-x. J Immunother Cancer. 2019. PMID: 31248461 Free PMC article. Clinical Trial.
11 results